Positive operating result and almost doubled sales for the fourth quarter

Q4 · Net sales reached SEK 42.3 (22.2) million. · Result after tax came in at SEK -0.3 (-5.3) million. · Earnings per share, basic and diluted, were SEK 0.00 (-0.04). · Cash and cash equivalents were SEK 24.0 (29.3) million. Full year · Net sales reached SEK 111.2 (61.3) million. · Result after tax came in at SEK -13.2 (-41.0) million. · Earnings per share, basic and diluted, were SEK -0.09(-0.29). Significant events during the quarter ·Enzymatica continued its international expansion. Sanofi launched ColdZyme® in France and Italy under its